<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39421504</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0970-0218</ISSN><JournalIssue CitedMedium="Print"><Volume>49</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Indian journal of community medicine : official publication of Indian Association of Preventive &amp; Social Medicine</Title><ISOAbbreviation>Indian J Community Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Tuberculosis Infection among Various Risk Groups in India: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>669</StartPage><EndPage>680</EndPage><MedlinePgn>669-680</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/ijcm.ijcm_36_24</ELocationID><Abstract><AbstractText>Treatment of tuberculosis (TB) infection (TBI) to prevent active TB disease is a key component of the National Strategic Plan to end TB in India, without which the strategies to end TB would be futile. There is a need to rapidly scale up access to effective shorter regimens for tuberculosis preventive treatment (TPT) to a wider set of risk groups. This applies for identifying high-risk groups for TPT expansion. Thus, our aim with this review is to determine the TBI prevalence in different risk groups in India. We searched databases like Embase, Medline, Scopus, and CINAHL for studies published between 2012 and 2023 to estimate TBI in different risk groups in India. The PRISMA guidelines were followed when reviewing the publications, and a predetermined search strategy was used to find relevant sources across various databases. Using MetaXL (MS excel) software, we pooled data based on a random-effects model, along with heterogeneity testing using Cochrane's Q and I<sup>2</sup> statistic. A total of 68 studies were included from 10,521 records. TBI pooled prevalence was estimated using the IGRA data, while in the absence of IGRA data, TST data were utilized. The key findings revealed a total of 36% pooled TBI prevalence for all risk factors, 59% among smokers, 53% among diabetics and alcoholics, 48% among malnourished, 47% among contacts of TB patients, 44% among HIV, 36% among pregnant women, 35% among COVID-19 patients, 31% among healthcare workers, 18% among sarcoidosis patients, and 15% among rheumatoid arthritis patients in India. Our review depicted a high TBI burden among groups such as diabetes mellitus, smokers, malnourished, and alcoholics. WHO has yet to recommend for systematic screening and treatment for TBI among these groups for want of evidence which this study provides, highlighting the need to reprioritize the risk groups for tailored TPT strategies.</AbstractText><CopyrightInformation>Copyright: © 2024 Indian Journal of Community Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Arohi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Scientist, Public Health Foundation of India, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parmar</LastName><ForeName>Malik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Professional Officer, Drug Resistant and Latent TB, WHO India, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dash</LastName><ForeName>Girish</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Technology Assessment Hub, Indian Council of Medical Research-Regional Medical Research Centre, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solanki</LastName><ForeName>Hardik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Consultant-Latent TB, Central TB Division, WHO NTEP Technical Support Network, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Consultant-Drug Resistant TB, Central TB Division, WHO NTEP Technical Support Network, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahoo</LastName><ForeName>Krushna Chandra</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Consultant (Public Health Specialist), Indian Council of Medical Research-Regional Medical Research Centre, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vadera</LastName><ForeName>Bhavin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Project Management Specialist, USAIDs, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Raghuram</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Central TB Division, Ministry of Health and Family Welfare, Government of India, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Central TB Division, Ministry of Health and Family Welfare, Government of India, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rade</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>International Technical Consultant, STOP TB Partnership, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pati</LastName><ForeName>Sanghamitra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Indian Council of Medical Research-Regional Medical Research Centre, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Community Med</MedlineTA><NlmUniqueID>9315574</NlmUniqueID><ISSNLinking>0970-0218</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Burden</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">risk groups</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">tuberculosis infection</Keyword></KeywordList><CoiStatement>Malik Parmar, Hardik Solanki, Sandeep Chauhan are affiliated to the World Health Organization (WHO). The views expressed in the submitted article are their own and not an official position of their respective institutions.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39421504</ArticleId><ArticleId IdType="pmc">PMC11482387</ArticleId><ArticleId IdType="doi">10.4103/ijcm.ijcm_36_24</ArticleId><ArticleId IdType="pii">IJCM-49-669</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076. doi: 10.1038/nrdp.2016.76.</Citation><ArticleIdList><ArticleId IdType="pubmed">27784885</ArticleId></ArticleIdList></Reference><Reference><Citation>Colangeli R, Gupta A, Vinhas SA, Chippada Venkata UD, Kim S, Grady C, et al. Mycobacterium tuberculosis progresses through two phases of latent infection in humans. Nat Commun. 2020 Sep 25;11:4870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519141</ArticleId><ArticleId IdType="pubmed">32978384</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Global TB report 2022.  Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Indian Council of Medical Research, Ministry of Health and Famly Welfare, Government of India, and Central TB Division, New Delhi  National TB prevalence survey in India.  Available from: https://tbcindia.gov.in/showfile.php?lid=3659 . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Chauhan A, Parmar M, Dash GC, Solanki H, Chauhan S, Sharma J, et al. The prevalence of tuberculosis infection in India: A systematic review and meta-analysis. Indian J Med Res. 2023;157:135–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10319385</ArticleId><ArticleId IdType="pubmed">37202933</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M, Dorman SE. Latent tuberculosis infection. N Engl J Med. 2021;385:2271–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">34879450</ArticleId></ArticleIdList></Reference><Reference><Citation>International Diabetes Federation. IDF Diabetes Atlas 10th Edition. 2021 Available from: https://diabetesatlas.org/atlas/tenth-edition/ . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Jindal SK. Silicosis in India: Past and present. Curr Opin Pulm Med. 2013;19:163–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23254775</ArticleId></ArticleIdList></Reference><Reference><Citation>National AIDS Control Organization  Sankalak Status of National AIDS Response. 2020 Available from https://naco.gov.in/sites/default/files/Sankalak%20Status%20of%20National%20AIDS%20Response,%20 Second%20Edition%20(2020).pdf . [Last accessed 2024 Mar 05]</Citation></Reference><Reference><Citation>Nguyen PH, Scott S, Headey D, Singh N, Tran LM, Menon P, et al. The double burden of malnutrition in India: Trends and inequalities (2006–2016) PLoS One. 2021;16:1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906302</ArticleId><ArticleId IdType="pubmed">33630964</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesham V. The problems and issues in urbanization in India Management History of Urbanization in India, Causes of urbanization in India, The Problems and issues in urbanization in India: Urban lounge. Paripex-Indian J Res. 2015;8:277–8.</Citation></Reference><Reference><Citation>Central TB Division, Directorate General of Health Services Ministry of Health with Family welfare  National Strategic Plan for Tuberculosis Elimination 2017-2025. 2017 Available from: https://tbcindia.gov.in/WriteReadData/NSP Draft 20.02.2017 1.pdf . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>World Health Organization  Guidelines on the management of latent tuberculosis infection. 2015 Available from: https://www.who.int/publications/i/item/9789241548908 . [Last accessed on 2024 Mar 05]</Citation><ArticleIdList><ArticleId IdType="pubmed">25973515</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox GJ, Nguyen TA, Coleman M, Trajman A, Velen K, Marais BJ. Implementing tuberculosis preventive treatment in high-prevalence settings. Int J Infect Dis. 2021;113:S13–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33716196</ArticleId></ArticleIdList></Reference><Reference><Citation>Stormacq C, Wosinski J, Boillat E, Den Broucke S Van. Effects of health literacy interventions on health-related outcomes in socioeconomically disadvantaged adults living in the community: A systematic review. JBI Evid Synth. 2020;18:1389–469.</Citation><ArticleIdList><ArticleId IdType="pubmed">32813388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic Reviews of Effectiveness. In. 2020</Citation></Reference><Reference><Citation>Agarwal S, Das SK, Agarwal GG, Srivastava R. Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: Implications on anti-TNF therapies. Interdiscip Perspect Infect Dis. 2014;2014:430134. doi: 10.1155/2014/430134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953622</ArticleId><ArticleId IdType="pubmed">24707285</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal SK, Singh UB, Zaidi SH, Gupta S, Pandey RM. Comparison of interferon gamma release assay and tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis. Indian J Med Res. 2015 Apr;141:463–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4510727</ArticleId><ArticleId IdType="pubmed">26112848</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya S, Kumar SK, Nath A, Kapoor P, Aggarwal A, Misra R, et al. Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell- membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting. PLoS One. 2018;13:e0204429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6152960</ArticleId><ArticleId IdType="pubmed">30248144</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravindhan V, Viswanathan V. Unique reciprocal association seen between latent tuberculosis infection and diabetes is due to immunoendocrine modulation. Front Microbiol. 2022;13:884374. doi: 10.3389/fmicb.2022.884374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9271927</ArticleId><ArticleId IdType="pubmed">35832818</ArticleId></ArticleIdList></Reference><Reference><Citation>Priya Bajgai, Sharma K, Ms RB, Gupta N, Bajgai P. Detection of mycobacterium tuberculosis genome in subretinal fluid of patients with latent tuberculosis infection detection of mycobacterium tuberculosis genome in subretinal fluid of patients with latent tuberculosis infection. Ocul Immunol Inflamm. 2015;24:615–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26645647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bari SA, Sultana Q, Jalily QA, Eshwar MD, Dodda S. Assessment of the occupational risk of tuberculosis and air borne infection control in high-risk hospital wards and its implications on healthcare workers in a tertiary care hospital in South India. Cureus. 2023;15:e33785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931371</ArticleId><ArticleId IdType="pubmed">36819336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, et al. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations. BMC Infect Dis. 2020;20:96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6995184</ArticleId><ArticleId IdType="pubmed">32005136</ArticleId></ArticleIdList></Reference><Reference><Citation>Benachinmardi KK, Sangeetha S, Rao M, Prema R. Validation and clinical application of interferon-gamma release assay for diagnosis of latent tuberculosis infection in children. Int J Appl Basic Med Res. 2019;9:241–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822318</ArticleId><ArticleId IdType="pubmed">31681551</ArticleId></ArticleIdList></Reference><Reference><Citation>Benachinmardi K, Sampath S, Rao M. Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting. Int J Mycobacteriol. 2021;10:142–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34558465</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddu D, Verghese VP, Michael JS, Chacko A, Jeyaseelan V. Utility of QuantiFERON ®-TB Gold In-Tube test compared with tuberculin skin test in diagnosing tuberculosis in Indian children with malnutrition. Indian J Med Microbiol. 2019;37:433–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32003347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Vijay S, Yogendra B, et al. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS One. 2018;13:e0199360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070176</ArticleId><ArticleId IdType="pubmed">30067752</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan S, Gahalaut P, Rathi AK. Tuberculin Skin Test, chest radiography and contact screening in children ≤5 y: Relevance in Revised National Tuberculosis Control Programme (RNTCP) Indian J Pediatr. 2013;80:276–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22688652</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher DJ, Pai M, Zwerling A. Safety of the two-step tuberculin skin test in Indian health care workers. Int J Mycobacteriology. 2014;3:247–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">26786623</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayal R, Agarwal D, Bhatia R, Bipin C, Yadav NK, Kumar S, et al. Tuberculosis burden among household pediatric contacts of adult tuberculosis patients. Indian J Pediatr. 2018;85:867–71.</Citation><ArticleIdList><ArticleId IdType="pubmed">29557089</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabhi PA, Thangakunam B, Gupta R, James P, Thomas N, Naik D, et al. Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital. PLoS One. 2020;15:e0233385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274437</ArticleId><ArticleId IdType="pubmed">32502176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkar PK, Kumar S, Kumar S, Verma SK, Kumar S, Kamal A, et al. To study the prevalence of latent tuberculosis infection among medical students. Indian J Comm Health. 2022;34:284–8.</Citation></Reference><Reference><Citation>Dolla CK, Padmapriyadarsini C, Thiruvengadam K, Lokhande R, Kinikar A, Paradkar M, et al. Age-specific prevalence of TB infection among household contacts of pulmonary TB : Is it time for TB preventive therapy ? Trans R Soc Trop Med Hyg. 2019;113:632–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792162</ArticleId><ArticleId IdType="pubmed">31225622</ArticleId></ArticleIdList></Reference><Reference><Citation>Girish S, Kinikar A, Pardeshi G, Shelke S, Basavaraj A, Chandanwale A, et al. Utility of the Interferon-Gamma release assay for latent tuberculosis infection screening among Indian Health-Care Workers. Indian J Community Med. 2021;46:281–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8281831</ArticleId><ArticleId IdType="pubmed">34321742</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, et al. Feasibility of identifying household contacts of rifampin-and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease. Clin Infect Dis. 2020;70:425–35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188224</ArticleId><ArticleId IdType="pubmed">30942853</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Sural S, Gupta A, Rousa S. Positive QuantiFERON test and the severity of COVID-19 disease: A prospective study Ajay. Indian J Tuberc. 2021;68:474–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7927586</ArticleId><ArticleId IdType="pubmed">34752316</ArticleId></ArticleIdList></Reference><Reference><Citation>James PM, Ganaie FA, Kadahalli RL. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population. J Int Assoc Provid AIDS Care. 2014;13:47–55.</Citation><ArticleIdList><ArticleId IdType="pubmed">23482341</ArticleId></ArticleIdList></Reference><Reference><Citation>Janagond AB, Ganesan V, Vijay Kumar GS, Ramesh A, Anand P, Mariappan M. Screening of health-care workers for latent tuberculosis infection in a tertiary care hospital. Int J Mycobacteriology. 2017;6:253–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28776523</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenum S, Selvam S, Mahelai D, Jesuraj N, Cárdenas V, Kenneth J, et al. Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in. Pediatr Infect Dis J. 2014;33:260–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4165482</ArticleId><ArticleId IdType="pubmed">24797993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeer B, Paramasivam P, Raja A. Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection. J Infect. 2012;64:573–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3350596</ArticleId><ArticleId IdType="pubmed">22381458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul S, Nair V, Birla S, Dhawan S, Rathore S, Khanna V, et al. Latent tuberculosis infection diagnosis among household contacts in a high tuberculosis-burden area : A comparison between. Microbiol Spectr. 2022;10:e0244521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045189</ArticleId><ArticleId IdType="pubmed">35416716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubiak RW, Sarkar S, Horsburgh CR, Roy G, Kratz M, Reshma A, et al. Interaction of nutritional status and diabetes on active and latent tuberculosis : A cross-sectional analysis. BMC Infect Dis. 2019;19:627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636094</ArticleId><ArticleId IdType="pubmed">31311495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Hesseling AC, Wu X, Hughes MD, Shah NS, Gaikwad S, et al. Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household. PLoS Negl Trop Dis. 2023;18:e0283290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10022776</ArticleId><ArticleId IdType="pubmed">36930628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinikar A, Chandanwale A, Kadam D, Joshi S, Basavaraj A, Pardeshi G, et al. High risk for latent tuberculosis infection among medical residents and nursing students in India. PLoS One. 2019;14:e0219131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613683</ArticleId><ArticleId IdType="pubmed">31283794</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthy Y, Ezhumalai K, Murali S, Jose M, Sathishkumar A, Soundappan G, et al. Prevalence and risk factors associated with latent tuberculosis infection among household contacts of smear positive pulmonary tuberculosis patients in South India. Trop Med Int Heal. 2021;26:1645–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">34654061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar GSV, Gopalakrishnan R. Detection of latent tuberculosis infection in nursing students by combined TST and IGRA serial testing. J Med Sci Clin Res. 2014;2:567–74.</Citation></Reference><Reference><Citation>Kumar MG, Joseph B, Goud BR, Joseph M, Rajitha M. Risk of tuberculosis infection among healthcare workers in a tertiary care hospital in bengaluru city. Indian J Occup Environ Med. 2019;23:83–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6783525</ArticleId><ArticleId IdType="pubmed">31619881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Vuyyuru SK, Kante B, Sahu P, Goyal S, Madhu D, et al. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region. Aliment Pharmacol Ther. 2022;55:1431–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">35229906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar NP, George PJ, Kumaran P, Dolla CK, Nutman TB, Babu S. Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent mycobacterium tuberculosis infection. J Infect Dis. 2014;210:1670–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215076</ArticleId><ArticleId IdType="pubmed">24907382</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan M, Baldwa B, Raja A, Tyagi R, Dwivedi T, Mohan A, et al. Impact of latent tuberculosis on severity and outcomes in admitted COVID-19 patients. Cureus. 2021;13:e19882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709920</ArticleId><ArticleId IdType="pubmed">34966601</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan K, Sryma PB, Pattnaik B, Mittal S, Tiwari P, Hadda V, et al. Clinical profile of 327 patients with Sarcoidosis in India: An Ambispective Cohort Study in a Tuberculosis (TB) endemic population. Lung India. 2022;39:51–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926222</ArticleId><ArticleId IdType="pubmed">34975053</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaviya AN, Aggarwal VK, Rawat R, Baghel S, Thakran R, Zaheer Q, et al. Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease-modifying anti-rheumatic drugs in India, a high-burden TB country : The importance of Mantoux and Quantiferon-TB G. Int J Rheum Dis. 2018;21:1563–71.</Citation><ArticleIdList><ArticleId IdType="pubmed">29345081</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaviya AN, Thakaran R, Rawat R, Kapoor S, Garg S, Baghel SS, et al. Real life experience of a screening strategy for latent tuberculosis before treatment with biologicals in Indian patients with rheumatic diseases. Indian J Rheumatol. 2018;13:233–9.</Citation></Reference><Reference><Citation>Mantri AK, Meena P, Puri AS, Kumar A, Sachdeva S, Srivastava S, et al. Comparison of interferon-gamma release assay and tuberculin skin test for the screening of latent tuberculosis in inflammatory bowel disease patients : Indian scenario. Tuberc Res Treat. 2021;2021:6682840. doi: 10.1155/2021/6682840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857923</ArticleId><ArticleId IdType="pubmed">33575041</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathad JS, Bhosale R, Sangar V, Mave V, Gupte N, Kanade S, et al. Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting. PLoS One. 2014;9:e92308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962385</ArticleId><ArticleId IdType="pubmed">24658103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, et al. Quantitative IFN- g and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women. Am J Respir Crit Care Med. 2016;193:1421–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910889</ArticleId><ArticleId IdType="pubmed">26765255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mave V, Chandrasekaran P, Chavan A, Shivakumar SVBY, Danasekaran K, Paradkar M, et al. Infection free “resisters” among household contacts of adult pulmonary tuberculosis. PLoS One. 2019;14:e0218034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6638997</ArticleId><ArticleId IdType="pubmed">31318864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S, Singh SK, Mohan U, Sahu R, Verma AK. Risk factors associated with tuberculosis infection among household children contacts of sputum smear positive tuberculosis cases. Indian J Community Heal. 2017:29.</Citation></Reference><Reference><Citation>Narasimhan P, Raina C, Mathai D, Wood J. High rates of latent TB infection in contacts and the wider community in South India. Trans R Soc Trop Med Hyg. 2017;111:55–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28407146</ArticleId></ArticleIdList></Reference><Reference><Citation>Neema S, Radhakrishnan S, Dabbas D, Vasudevan B. Latent tuberculosis in psoriasis patients planned for systemic therapy-A prospective observational study. Indian Dermatol Online J. 2021;12:429–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8202497</ArticleId><ArticleId IdType="pubmed">34211910</ArticleId></ArticleIdList></Reference><Reference><Citation>Neema S, Sandhu S, Mukherjee S, Vashisht D, Vendhan S, Sinha A, et al. Comparison of IGRA and TST for diagnosis of latent tuberculosis in psoriais patients planned for systemic therapy. Indian J Dermatology. 2022;67:19–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9154176</ArticleId><ArticleId IdType="pubmed">35656280</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattnaik B, Pb S, Verma M, Kumar S, Mittal S, Arava S, et al. Patient profile and comparison of three diagnostic criteria for cardiac sarcoidosis in a tuberculosis endemic population. Sarcoidosis Vasc diffues lung Dis. 2022;38:e2021040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787371</ArticleId><ArticleId IdType="pubmed">35115747</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradkar M, Padmapriyadarsini C, Jain D, Vijay S, Yogendra B, Id S, Thiruvengadam K, et al. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS One. 2020:8–19. doi: 10.1371/journal.pone.0236743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390377</ArticleId><ArticleId IdType="pubmed">32726367</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhavathi M, Kabeer BS, Deenadayalan A, Raja A. Role of QuantiFERON-TB Gold antigen-specific IL-1 β in diagnosis of active tuberculosis. Med Microbiol Immunol. 2015;205:567–74.</Citation><ArticleIdList><ArticleId IdType="pubmed">25504009</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S, Phutane M, Mundkar S. Role of tuberculin skin test in latent tuberculosis infection in HIV patients in a tertiary care hospital of India. J Transl Intern Med. 2014;2:136–42.</Citation></Reference><Reference><Citation>Rajamanickam A, Pavan N, Padmapriyadarsini C, Nancy A, Selvaraj N, Karunanithi K, et al. Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection. J Infect. 2021;83:339–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316716</ArticleId><ArticleId IdType="pubmed">34329676</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajalakshmi KV, Anbalagan VP. Prevalence of latent tuberculosis infection in type 2 diabetic and non- diabetic individuals. J Med Sci Clin Res. 2017;5:23617–23.</Citation></Reference><Reference><Citation>Reddy D, Ma Y, Lakshminarayanan S, Sahu S, White F, Reshma A, et al. Severe undernutrition in children affects tuberculin skin test performance in Southern India. PLoS One. 2021;16:1–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8284816</ArticleId><ArticleId IdType="pubmed">34270546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawhney N, Mehta S, Shinu P, Singh V. Prevalence of latent tuberculosis infection among hospital workers in a tertiary care referral centre. Int J Adv Heal Sci. 2015;2:585–91.</Citation></Reference><Reference><Citation>Shah I, Kathwate J, Shetty NS. Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube test in Bacillus Calmette-Guerin-vaccinated children. Lung India. 2020;37:24–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961094</ArticleId><ArticleId IdType="pubmed">31898617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma SK, Vashishtha R, Chauhan LS, Sreenivas V, Seth D. Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB- burden setting. PLoS One. 2017;12:e0169539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5218498</ArticleId><ArticleId IdType="pubmed">28060926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivakumar SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavarshini N, et al. Diabetes and pre-diabetes among household contacts of tuberculosis patients in India : Is it time to screen them all ? Int J Tuberc Lung Dis. 2018;22:686–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">29862955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobha V, Chandrashekara VSS, Kumar S, Ashwin M, Yogesh D, Uma S, et al. Biologics and risk of tuberculosis in autoimmune rheumatic diseases : A real ‐ world clinical experience from India. Int J Rheum Dis. 2019;22:280–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30168281</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava G, Faridi MMA, Gupta SS. Tubercular infection in children living with adults receiving Directly Observed Treatment Short Course (DOTS): A follow up study. BMC Infect Dis. 2020;20:720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528466</ArticleId><ArticleId IdType="pubmed">33004004</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J, Sankar MM, Kumar S, Gopinath K, Singh N. Incidence and prevalence of tuberculosis among household contacts of pulmonary tuberculosis patients in a peri-urban population of South Delhi, India. PLoS One. 2013;8:e69730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3724886</ArticleId><ArticleId IdType="pubmed">23922784</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Fatima N, Shukla I, Shameem M. Evaluation of role of interferon gamma release assays in the diagnosis of latent tuberculosis in human immunodeficiency virus-infected patients. Indian J Sex Trasnm Dis. 2021;42:111–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628109</ArticleId><ArticleId IdType="pubmed">34909614</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui M, Khan S, Bhutia R, Nair V, Gurung N, Yamphel T, et al. Prevalence and factors associated with latent tuberculosis infection among residents of a monastery situated in a high-TB burden area: A cross sectional study, Sikkim, India. 2022:1–18. doi: 10.21203/rs.3.rs-1872450/v1.</Citation></Reference><Reference><Citation>Surve S, Bhor V, Naukariya K, Begum S, Munne K, Tipre P, et al. Discordance between TST and QFT-TBGold plus for latent tuberculosis screening among under-five children : An interim analysis study design. J Trop Med. 2021;67:1–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34904674</ArticleId></ArticleIdList></Reference><Reference><Citation>Thamke R, Kamale V, Rajan R. Assessment of children in contact with sputum positive adult patients with respect to TB disease and latency. New Indian J Pediatr. 2018;7:229–38.</Citation></Reference><Reference><Citation>Vyas S, Thangakunam B, Gupta R, Michael JS, Christopher DJ. Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis. Lung India. 2015;32:91–2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298936</ArticleId><ArticleId IdType="pubmed">25624613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwerling A, Pai M, Michael JS, Christopher DJ. Serial testing using interferon-γ release assays in nursing students in India. Eur Respir J. 2014;44:257–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">24696119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zia A, Kumar A, Khan MA, Kumar U, Vyas S, Vishwakarma VK, et al. The interplay of disease modifying anti rheumatic drugs and tuberculin skin test. Curr Rev Clin Exp Pharmacol. 2021;16:350–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33390147</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . Module 1: Prevention. Tuberculosis preventive treatment. WHO; 2020. WHO consolidated guidelines on tuberculosis. Available from: https://iris.who.int/bitstream/handle/10665/331170/9789240001503-eng.pdf?sequence=1,last.  [Last accessed on 2024 May 15]</Citation><ArticleIdList><ArticleId IdType="pubmed">32186832</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton NI, Borand L, Benedicto J, Mar M, Mujtaba A, Nor M, et al. International Journal of Infectious Diseases Diagnosis and management of latent tuberculosis infection in Asia : Review of current status and challenges. Int J Infect Dis. 2019;87:21–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31301458</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention Committee of the Japanese Society for Tuberculosis; Treatment Committee of the Japanese Society for Tuberculosis Treatment guidelines for latent tuberculosis infection. Kekkaku. 2014;89:21–37.</Citation><ArticleIdList><ArticleId IdType="pubmed">24654427</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Journey of TB preventive treatment (TPT) provision in Myanmar. WHO international.  Available from: https://www.who.int/myanmar/activitiesjourney-of-tb-preventive-treatment-(tpt)-provision-in-myanmar . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Department of Health National TB control Program Phillipines  TB (DS and DR) and Latent TB Screening, Diagnosis and Management. 2020 Available from: https://ntp.doh.gov.ph/download/tb-ds-dr-and-latent-tb-screening-diagnosis-and-management-pocket-guide/ . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Department of Health Republic of the Philippines  Guidelines on expanded eligibility for LTBI treatment. 2019 Available from: https://ntp.doh.gov.ph/download/dm-2019-0257/ . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Aabye MG, Hermansen TS, Ruhwald M, PrayGod G, Faurholt-Jepsen D, Jeremiah K, et al. Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test. BMC Infect Dis. 2012;12:2–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3546031</ArticleId><ArticleId IdType="pubmed">23270417</ArticleId></ArticleIdList></Reference><Reference><Citation>Velen K, Shingde RV, Ho J, Fox GJ. The effectiveness of contact investigation among contacts of tuberculosis patients: A systematic review and meta-analysis. Eur Respir J. 2021;58:2100266.</Citation><ArticleIdList><ArticleId IdType="pubmed">34016621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap RS, Nayak AR, Gaherwar HM, Husain AA, Shekhawat SD. Latent TB infection diagnosis in population exposed to TB Subjects in close and poor ventilated high TB endemic zone in India. PLoS One. 2014;9:e89524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948673</ArticleId><ArticleId IdType="pubmed">24614179</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas TA, Mondal D, Noor Z, Liu L, Alam M, Haque R, et al. Malnutrition and Helminth infection affect performance of an interferon γ–release assay tania. Pediatrics. 2010;126:1522–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3403682</ArticleId><ArticleId IdType="pubmed">21059723</ArticleId></ArticleIdList></Reference><Reference><Citation>Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis : A systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019;7:e448–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">30819531</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, et al. Diabetes and the risk of tuberculosis: A neglected threat to public health? Chronic Illn. 2007;3:228–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083679</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med. 2008;5:e152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2459204</ArticleId><ArticleId IdType="pubmed">18630984</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister SM, Koesoemadinata RC, Santoso P, Soetedjo NNM, Kamil A, Permana H, et al. High tuberculosis incidence among people living with diabetes in Indonesia. Trans R Soc Trop Med Hyg. 2020;114:79–85.</Citation><ArticleIdList><ArticleId IdType="pubmed">31711230</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes SP, Di M, Salomon J, Linas BP, Trikalinos TA. Evidence synthesis for diagnostic tests with partially ordered performance and no reference test. Value Heal. 2017;20:A325.</Citation></Reference><Reference><Citation>Koesoemadinata RC, McAllister SM, Soetedjo NNM, Febni Ratnaningsih D, Ruslami R, Kerry S, et al. Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia. Trans R Soc Trop Med Hyg. 2017;111:81–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28419376</ArticleId></ArticleIdList></Reference><Reference><Citation>Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, Wilson N, et al. The looming epidemic of diabetes-associated tuberculosis: Learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis. 2011;15:1436–44. i.</Citation><ArticleIdList><ArticleId IdType="pubmed">21902876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori MA, Leonardson G, Welty TK. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Arch Intern Med. 1992;152:547–50.</Citation><ArticleIdList><ArticleId IdType="pubmed">1546917</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Huang W, Lin K, Liu S, Lee M, Cheng M, et al. Completion rate and safety of programmatic screening and treatment for latent tuberculosis infection in elderly patients with poorly controlled diabetic mellitus : A prospective multicenter study. Clin Infect Dis. 2021;73:1252–60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8442788</ArticleId><ArticleId IdType="pubmed">33677558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Hu X, Zhao L, Hu M, Gao F. Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: Do we know enough? Drug Des Devel Ther. 2017;11:2957–68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644564</ArticleId><ArticleId IdType="pubmed">29066867</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng JY, Huang SF, Ting WY, Lee MC, Chen YC, Lin YY, et al. Impact of cigarette smoking on latent tuberculosis infection: Does age matter? Eur Respir J. 2014;43:630–2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24072215</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: A systematic review and meta-analysis. Arch Intern Med. 2007;167:335–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">17325294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: A systematic review and meta-analysis. PLoS Med. 2007;4:e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1769410</ArticleId><ArticleId IdType="pubmed">17227135</ArticleId></ArticleIdList></Reference><Reference><Citation>Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, et al. Tobacco and tuberculosis: A qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007;11:1049–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">17945060</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta KB, Gupta R, Atreja A, Verma M, Vishvkarma S. Tuberculosis and nutrition. Lung India. 2009;26:9–16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813110</ArticleId><ArticleId IdType="pubmed">20165588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health and Family Welfare, Government of India  Guidelines for Programmatic Management of Tuberculosis Preventive Treatment in India. 2021 Available from https://www.tbcindia.gov.in/showfile.php?lid=3625 . [Last accessed on 2024 Mar 05]</Citation></Reference><Reference><Citation>Prabhavathi M, Syed B, Kabeer A, Deenadayalan A. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects. Tuberculosis. 2015:5–8. doi: 10.1016/j.tube. 2015.10.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">26786651</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>